Toxic and Drug-Induced Myopathies
JNNP 80:832-838, Dalakas,M.C., 2009
Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients
Medicine 84:377-385, Melli,G.,et al, 2005
Pentazocine Abuse Masquerading as Familial Myopathy
Neurol 34:524-527, Choucair,A.K.,et al, 1984
The Spectrum of Statin Myopathy
Curr Opin Rheumatol 25:747-752, Mohassel, P. & Mammen, A.L., 2013
Clinicopathologic Conference,Necrotizing Noninflammatory Myopathy Consistent with Exposure to Statins
NEJM 36:944-954, Case 7-2012, 2012
Progressive Weakness with Respiratory Failure in a Patient with Sarcoidosis
Arch Neurol 69:534-537, Chaudhry,P.,et al, 2012
Statin Induced Myopathy
BMJ 337:1159-1162, Sathasivam,S. &Lecky,B., 2008
Safety of HMG-CoA Reductase Inhibitors: Focus on Atorvastatin
Cardiovasc Drugs Ther 15:211-218, Bernini,F.,et al, 2001
Chloroquine Myopathy and Neuropathy with Elevated CSF Protein
Neurol 51:1226-1227, Wasay,M.,et al, 1998
Myopathies Assoc with HIV and Zidovudine:Can Their Effects be Distinguished?
Neurol 43:971-976, Simpson,D.M.,et al, 1993
Sudden Onset of Profound Weakness in a Toddler
J Pediatr 122:663-667, Carraccio,C.,et al, 1993
Acute Myopathy and Neuropathy in Status Asthmaticus:Case Report and Literature Review
Muscle & Nerve 16:84-90993., Lacomis,D.,et al, 1993
Pravastatin-Associated Inflammatory Myopathy
NEJM 327:649-650, Schalke,B.B.,et al, 1992
Ipecac Myopathy and Cardiomyopathy
JNNP 56:560-562, Dresser,L.P.,et al, 1992
Prognosis in AZT Myopathy
Neurol 41:1181-1184, Chalmers,A.C.,et al, 1991
Mitochondrial Myopathy Caused by Long-Term Ziduvudine Therapy
NEJM 322:1098-1105, Dalakas,M.C.,et al, 1990
Current Concepts in the Idiopathic Inflammatory Myopathies:Polymyositis, Dermatomyositis, and Related Disorders
Ann Int Med 111:143-157, Plotz,P.H.,et al, 1989
Chloroquine Neuromyotoxicity, Clinical & Pathological Perspective
Am J Med 82:447-455, Estes,M.L.,et al, 1987
Reversible Ipecac Myopathy
Arch Neurol 42:188-190, Mateer,J.E.,et al, 1985
Transient Myopathy Apparently Due to Tetracycline
NEJM 307:821-822, Sinclair,D.,et al, 1982
Labetalol-induced Toxic Myopathy
BMJ 282:1824-1825, Teicher,A.,et al, 1981
Myopathy Due to Epsilon Amino-Caproic Acid
Muscle & Nerve 3:202-206980., Kennard,C.,et al, 1980